BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 20592901)

  • 1. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients.
    Ahn HJ; Chin J; Park A; Lee BH; Suh MK; Seo SW; Na DL
    J Korean Med Sci; 2010 Jul; 25(7):1071-6. PubMed ID: 20592901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking Cognitive Decline in Amnestic Mild Cognitive Impairment and Early-Stage Alzheimer Dementia: Mini-Mental State Examination versus Neuropsychological Battery.
    Kim J; Na HK; Byun J; Shin J; Kim S; Lee BH; Na DL
    Dement Geriatr Cogn Disord; 2017; 44(1-2):105-117. PubMed ID: 28768247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies.
    Seo EH; Lee DY; Lee JH; Choo IH; Kim JW; Kim SG; Park SY; Shin JH; Do YJ; Yoon JC; Jhoo JH; Kim KW; Woo JI
    Am J Geriatr Psychiatry; 2010 Sep; 18(9):801-9. PubMed ID: 20220577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test Your Memory-Spanish version (TYM-S): a validation study of a self-administered cognitive screening test.
    Muñoz-Neira C; Henríquez Chaparro F; Delgado C; Brown J; Slachevsky A
    Int J Geriatr Psychiatry; 2014 Jul; 29(7):730-40. PubMed ID: 24390843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Seoul Neuropsychological Screening Battery (SNSB) for Comprehensive Neuropsychological Assessment.
    Ryu HJ; Yang DW
    Dement Neurocogn Disord; 2023 Jan; 22(1):1-15. PubMed ID: 36814700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A total score for the CERAD neuropsychological battery.
    Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
    Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment.
    Fujiwara Y; Suzuki H; Yasunaga M; Sugiyama M; Ijuin M; Sakuma N; Inagaki H; Iwasa H; Ura C; Yatomi N; Ishii K; Tokumaru AM; Homma A; Nasreddine Z; Shinkai S
    Geriatr Gerontol Int; 2010 Jul; 10(3):225-32. PubMed ID: 20141536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japanese version of the Frontal Assessment Battery for dementia.
    Kugo A; Terada S; Ata T; Ido Y; Kado Y; Ishihara T; Hikiji M; Fujisawa Y; Sasaki K; Kuroda S
    Psychiatry Res; 2007 Sep; 153(1):69-75. PubMed ID: 17599465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.
    Ben Jemaa S; Attia Romdhane N; Bahri-Mrabet A; Jendli A; Le Gall D; Bellaj T
    J Alzheimers Dis; 2017; 60(1):11-21. PubMed ID: 28505978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the combination of the MMSE and clock drawing test (mini-clock) improve the detection of mild Alzheimer's disease and mild cognitive impairment?
    Cacho J; Benito-León J; García-García R; Fernández-Calvo B; Vicente-Villardón JL; Mitchell AJ
    J Alzheimers Dis; 2010; 22(3):889-96. PubMed ID: 20858951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
    Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
    Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and validity of the severe impairment battery (SIB) in Korean dementia patients.
    Ahn IS; Kim JH; Ku HM; Saxton J; Kim DK
    J Korean Med Sci; 2006 Jun; 21(3):506-17. PubMed ID: 16778398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment.
    Lee JY; Dong Woo Lee ; Cho SJ; Na DL; Hong Jin Jeon ; Kim SK; You Ra Lee ; Youn JH; Kwon M; Lee JH; Maeng Je Cho
    J Geriatr Psychiatry Neurol; 2008 Jun; 21(2):104-10. PubMed ID: 18474719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Korean Addenbrooke's Cognitive Examination for diagnosing Alzheimer's dementia and mild cognitive impairment in the Korean elderly.
    Heo JH; Lee KM; Park TH; Ahn JY; Kim MK
    Appl Neuropsychol Adult; 2012; 19(2):127-31. PubMed ID: 23373580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological assessment of severely demeted elderly: the severe cognitive impairment profile.
    Peavy GM; Salmon DP; Rice VA; Galasko D; Samuel W; Taylor KI; Ernesto C; Butters N; Thal L
    Arch Neurol; 1996 Apr; 53(4):367-72. PubMed ID: 8929160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects between 2 computerized cognitive training programs, Bettercog and COMCOG, on elderly patients with MCI and mild dementia: A single-blind randomized controlled study.
    Lee GJ; Bang HJ; Lee KM; Kong HH; Seo HS; Oh M; Bang M
    Medicine (Baltimore); 2018 Nov; 97(45):e13007. PubMed ID: 30407291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the Montreal Cognitive Assessment (MoCA) Index Scores: a Comparison with the Cognitive Domain Scores of the Seoul Neuropsychological Screening Battery (SNSB).
    Kim H; Yu KH; Lee BC; Kim BC; Kang Y
    Dement Neurocogn Disord; 2021 Jul; 20(3):28-37. PubMed ID: 34354755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
    Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.